Automated mobile technology for safe heart rhythm analysis at home
Novel, automated mobile heart rhythm analysis technology to start antiarrhythmic medications safely at home
This study is testing a new mobile app that helps people with atrial fibrillation start their heart medication safely at home, using smart technology to check their heart rhythms and predict any side effects, so they can avoid hospital visits and get the care they need more easily.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Safebeat Rx INC. NIH-funded |
| Lab location | 1 site (Carson, UNITED STATES) |
| Project ID | NIH-11191222 on NIH RePORTER |
What this research studies
This research focuses on developing a novel mobile technology that allows patients with atrial fibrillation to safely start antiarrhythmic medications from home. By utilizing a machine learning algorithm, the technology analyzes heart rhythm data to predict potential side effects of these medications, which traditionally require hospitalization for monitoring. This approach aims to reduce the need for hospital stays, making treatment more accessible and convenient for patients. The technology provides accurate QTc interval measurements from electrocardiograms, enabling personalized medication dosing with high precision.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with atrial fibrillation who are at low risk for heart rhythm complications.
Not a fit: Patients with high-risk profiles for arrhythmias or those who require immediate medical supervision will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for atrial fibrillation patients by allowing them to initiate treatment safely at home without hospitalization.
How similar studies have performed: Other research has shown promise in using mobile technology and machine learning for heart rhythm monitoring, indicating a potential for success in this novel approach.
Where this research is happening
Carson, UNITED STATES
- Safebeat Rx INC. — Carson, United States (Active)
Researchers
- Principal investigator: Navara, Rachita — Safebeat Rx INC.
- Study coordinator: Navara, Rachita
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.